Results 1 to 10 of about 2,681,651 (342)
Some of the next articles are maybe not open access.
Monoclonal Antibody TfR Monoclonal Antibody.
Monoclonal antibodies in immunodiagnosis and immunotherapy, 2017semanticscholar +1 more source
F4/80, a monoclonal antibody directed specifically against the mouse macrophage
European Journal of Immunology, 1981J. Austyn, S. Gordon
semanticscholar +1 more source
Monoclonal antibodies and antibody cocktails are a promising therapeutic and prophylaxis for COVID-19. However, ongoing evolution of SARS-CoV-2 can render monoclonal antibodies ineffective.
Tyler N. Starr +3 more
semanticscholar +1 more source
Neisseria gonorrhoeae (gonococcus) is an obligate human pathogen and the etiological agent of the sexually transmitted disease gonorrhea. The rapid rise in gonococcal resistance to all currently available antimicrobials has become a significant public ...
Samuele Stazzoni +7 more
doaj +1 more source
GPI-Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications [PDF]
Background: We have previously reported the aberrant expression of Fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). Although FMOD has been considered as a cytoplasmic or secretory protein, we discovered the cell surface expression
Lia Farahi +8 more
doaj +1 more source
A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
Antimicrobial resistance (AMR) is a quickly advancing threat for human health worldwide and almost 5 million deaths are already attributable to this phenomenon every year.
Marco Troisi +6 more
doaj +1 more source
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Here, Andreano and Paciello et al. show, at single cell level, the functional and genetic characteristics underlying the Omicron BA.1 and BA.2 cross-protective antibody response in naïve and previously infected COVID-19 vaccinees.
Emanuele Andreano +18 more
doaj +1 more source
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Monoclonal antibodies (mAbs), the new revolutionary class of medications, are fast becoming tools against various diseases thanks to a unique structure and function that allow them to bind highly specific targets or receptors.
Pardis Mokhtary +4 more
doaj +1 more source
Monoclonal antibodies (mAbs) have been a valuable tool to elucidate several biological processes, such as stem cell differentiation and cancer, and contributed to virtually all areas of biomedical sciences.
Marina de Lima Fontes +7 more
doaj +1 more source

